A pilot study on acupuncture for lower urinary tract symptoms related to chronic prostatitis/chronic pelvic pain by Capodice, Jillian L et al.
BioMed  Central
Page 1 of 7
(page number not for citation purposes)
Chinese Medicine
Open Access Research
A pilot study on acupuncture for lower urinary tract symptoms 
related to chronic prostatitis/chronic pelvic pain
Jillian L Capodice*1, Zhezhen Jin2, Debra L Bemis1, David Samadi1, 
Brian A Stone1, Steven Kapan3 and Aaron E Katz1
Address: 1Department of Urology, Columbia University Medical Center, New York, NY 10032, USA, 2Department of Biostatistics, Columbia 
University Medical Center, New York, NY, 10032, USA and 3Department of Urology, Weill Cornell Medical College, New York, NY, 10022, USA
Email: Jillian L Capodice* - jc2346@columbia.edu; Zhezhen Jin - zj7@columbia.edu; Debra L Bemis - dlb2004@columbia.edu; 
David Samadi - ds2148@columbia.edu; Brian A Stone - bas28@columbia.edu; Steven Kapan - kaplans@med.cornell.edu; 
Aaron E Katz - aek4@columbia.edu
* Corresponding author    
Abstract
Background: The etiology and treatment of chronic prostatitis/chronic pelvic pain syndrome (CP/
CPPS) remain poorly understood. Pain, lower urinary tract voiding symptoms and negative impact
on quality of life (QOL) are the most common complaints. Acupuncture, which has been widely
used to treat painful and chronic conditions, may be a potential treatment to alleviate the
constellation of symptoms experienced by men with CP/CPPS. The purpose of our study was to
assess the impact of standardized full body and auricular acupuncture in men refractory to
conventional therapies and collect pilot data to warrant further randomized trials.
Methods: Ten men diagnosed with category IIIA or IIIB CP/CPPS >6 months, refractory to at least
1 conventional therapy (antibiotics, anti-inflammatory agents, 5-α reductase inhibitors, α-1
blockers) and scoring >4 on the pain subset of the NIH-CPSI were prospectively analyzed in an
Institutional Review Board (IRB) approved, single-center clinical trial (Columbia University Medical
Center IRB#AAAA-7460). Standardized full body and auricular acupuncture treatment was given
twice weekly for 6 weeks. The primary endpoints were total score of the NIH-CPSI and assessment
of serious adverse events. The secondary endpoints were individual scores of the NIH-CPSI and
QOL questionnaire scores of the short-form 36 (SF-36).
Results: The median age of the subjects was 36 years (range 29–63). Decreases in total NIH-CPSI
scores (mean ± SD) after 3 and 6 weeks from baseline (25.1 ± 6.6) were 17.6 ± 5.7 (P < 0.006) and
8.8 ± 6.2 (P < 0.006) respectively and remained significant after an additional 6 weeks of follow-up
(P < 0.006). Symptom and QOL/NIH-CPSI sub-scores were also significant (P < 0.002 and P < 0.002
respectively). Significance in 6 of 8 categories of the SF-36 including bodily pain (P < 0.002) was
achieved. One regression in the SF-36 vitality category was observed after follow-up. There were
no adverse events.
Conclusion: The preliminary findings, although limited, suggest the potential therapeutic role of
acupuncture in the treatment of CP/CPPS. Data from this and previous studies warrant randomized
trials of acupuncture for CP/CPPS and particular attention towards acupuncture point selection,
treatment intervention, and durability of acupuncture.
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Background
The etiology for chronic prostatitis/chronic pelvic pain
syndrome (CP/CPPS) has not been fully elucidated and
the current treatment strategies for CP/CPPS are not uni-
versally accepted [1]. Chronic infection, inflammation,
neuropathy, pelvic floor muscle dysfunction, autoim-
mune disease and neurobehavioral disorders are some of
the postulated etiologies though no single factor is
thought to be the absolute cause. Standard therapies for
CP/CPPS include antibiotics, anti-inflammatory agents,
5-α reductase inhibitors, and α-1 blockers [1-3]. Recently,
a multi-modal treatment approach and the utilization of
complementary and alternative medicine (CAM) strate-
gies such as acupuncture and phytotherapy have also been
suggested as potential treatment options for CP/CPPS [4-
7].
Acupuncture which has been used to treat painful and
chronic conditions [8,9] may be useful in the treatment of
pain, urinary and quality of life (QOL) symptoms fre-
quently seen in men with CP/CPPS. While the etiology,
treatment, long-term effects on QOL and CP/CPPS as a
predictor of future prostate disease are yet to be deter-
mined, the rationale for safe and effective treatment prac-
tices for this complex condition is needed. This pilot study
was implemented in order to test the efficacy of full body
and auricular acupuncture on pain, urinary and QOL
symptoms related to CP/CPPS and inform future research
and randomized clinical trials of acupuncture for the
management of symptoms related to CP/CPPS.
Methods
Patients
Our target sample size was 10 men diagnosed with CP/
CPPS who were also refractory to conventional therapies.
Subjects being treated at or referred to the Department of
Urology, Columbia University Medical Center between
April and September 2005 were offered participation in
the study (Columbia University Medical Center, Institu-
tional Review Board approved, IRB# AAAA-7460). The
Department of Urology, Columbia University Medical
Center, is located in New York (New York, USA) and has
a large, diverse patient population. The inclusion criteria
were men between the ages of 18 and 65, previous diag-
nosis with category IIIA or IIIB chronic prostatitis for >6
months, refractory to at least 1 conventional therapy
(antibiotics, anti-inflammatory agents, 5-α reductase
inhibitors or α-1 blockers), scoring >4 on the pain subset
of the NIH-CPSI, and able to read and sign the informed
consent.
Exclusion criteria were prostate cancer, bladder cancer,
testicular cancer, stone disease, neurogenic bladder dys-
function, interstitial cystitis, urethritis, active sexually
transmitted diseases (chlamydia, gonorrhea, syphilis,
active herpes simplex virus) active urinary tract infection,
bleeding disorders, skin infection, chronic use of anti-
inflammatory agents (defined as use >2 times per week),
active use of phytotherapeutic agents (saw palmetto,
cernilton, quercetin) and previous acupuncture treatment
within the past 6 months.
Acupuncture intervention
The protocol consisted of a standardized set of acupunc-
ture points given twice weekly for 30 minutes over 6
weeks based on traditional Chinese medicine organ (zang-
fu) and meridian theory. Points were selected based on
standard texts, informal practitioner query and expertise,
and selected points from previous studies [6,10-12].
Standardized full body and auricular acupuncture was
performed by JC throughout the study. An initial informal
piloting of the protocol included enactment of the stand-
ardized point prescription in two adult, consenting and
non-study patients. Acupuncture needles were single-use,
sterile and disposable. Full body acupuncture needles
were 25 mm or 40 mm (34 gauge) and auricular needles
were 15 mm (36 gauge). The needling protocol consisted
of first needling auricular points, followed by full-body
points. Needles were inserted to the proper needling
depth as determined by standard point locations [10-12]
and a de qi sensation was obtained. De qi is defined as a
feeling of soreness, numbness, distention, or heaviness
around the point after the needle is inserted to a certain
depth, meanwhile, the practitioner may feel a sense of
tenseness around the needle [10]. The needles remained
in situ for 20–25 minutes during which time the acupunc-
turist returned to stimulate the needles once utilizing
scraping (defined as scraping the handle of the needle up
to six times) and even needle technique (defined as lightly
rotating the needle back and forth up to six times) in order
to re-elicit the de qi sensation. The body acupuncture
points given at each visit included SJ 5-wai guan (alternate
name TB 5), GB 41-zulin qi, LR 3-tai chong, LI 4-he gu, SP
8-di ji and SP 6-san yin jiao. The auricular acupuncture
points needled at each visit in one ear and alternating ears
with each treatment included shen men, kidney, liver, lung
and spleen (Figure 1). There were no additional co-inter-
ventions.
Outcome measures
NIH-CPSI
The subjects enrolled in the study completed the stand-
ardized National Institute of Health chronic prostatitis
symptom index (NIH-CPSI) at baseline (0 week), mid-
point (3 weeks), endpoint (6 weeks) and follow-up (12
weeks).
Short-form 36 (SF-36)
The subjects enrolled in the study completed the stand-
ardized short-form 36 (SF-36) at baseline (0 week), mid-Chinese Medicine 2007, 2:1 http://www.cmjournal.org/content/2/1/1
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point (3 weeks), endpoint (6 weeks) and follow-up (12
weeks).
All investigators except ZJ (statistician) were blinded to
the questionnaire answers and study results until comple-
tion of the study.
Sample size and statistical analysis
We determined our sample size based on previous studies
[6,7] and determination of treatment effect with a maxi-
mum allowable difference of 0.1 and confidence level of
95% of our primary outcome measure, i.e. the NIH-CPSI.
Each of the measures was summarized by mean ± stand-
ard deviation at each measurement week (0, 3, 6, 12). The
changes of symptom measures at weeks 3, 6 and 12 com-
pared to baseline (0 week) were assessed by the paired
Wilcoxon signed test. P-values less than 0.05 are consid-
ered significant. All statistical analyses were carried out
with the statistical software package SAS version 9.1.
Results
Of 14 men screened for the study, 10 fit the inclusion/
exclusion criteria and were enrolled into the study follow-
ing informed consent. The median age of the 10 subjects
was 36 years (range 29 to 63). The previous use of conven-
tional therapies, i.e. antibiotics, non-steroidal anti-
inflammatory drugs, 5-α reductase inhibitors and α-1
blockers, was as follows: antibiotics (quinilones: levo-
floxacin or ciprofloxacin) 10 of 10, non-steroidal anti-
inflammatory drugs (ibuprofen, naproxen, cyclooxygen-
ase-2 inhibitors) 6 of 10, and 5-α reductase inhibitors
(finasteride) 3 of 10, and α-1 blockers (terazosin) 1 of 10.
All 10 patients completed the study period and assess-
ments at the scheduled time except for the 6-week follow-
up (median 6 weeks, range 5.5–7.1).
The decreases in the NIH-CPSI scores (mean ± SD) after 3
weeks (17.6 ± 5.7), 6 weeks of acupuncture (8.8 ± 6.2)
and 6 weeks of follow-up (6.6 ± 4.3) from baseline (25.1
± 6.6) were remarkably significant (P < 0.006). Decreases
in the total symptom (pain + urinary) and quality of life
(QOL) components of the NIH-CPSI were also considered
significant (P < 0.002 and P < 0.002 respectively) (Table
1). The changes of QOL measures utilizing the SF-36 at
weeks 3, 6 and 12 compared to baseline confirmed signif-
icant changes in 6 of 8 categories of the SF-36 after 6 weeks
of acupuncture treatment (Table 2). The significant cate-
gories included physical function (P < 0.016), role limita-
tions due to physical health (P < 0.016), role limitations
due to emotional health (P < 0.047), vitality (P < 0.037),
social functioning (P < 0.008) and bodily pain (P <
0.002). One regression in the vitality category was
observed after the 12 week follow-up (P = 0.111) (Table
2). There were no reported adverse events or important
medical events as defined by our data and safety-monitor-
Diagram of acupuncture points Figure 1
Diagram of acupuncture points. A. Acupuncture points located on the arm* B. Acupuncture points located on the legs* C. 
Auricular acupuncture points**. *These points were applied bilaterally. **These points were applied in one ear and alternated 
with each treatment visit.
 
 
 
 
 
 
 
A.                             B.                                              C. 
. 
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ing plan. One case of slight bruising at GB 41 was reported
in a single patient on one occasion. No other side effects
were reported.
Discussion
Though the etiology of CP/CPPS remains poorly under-
stood, the gold standard of treatment is the use of fluro-
quinilones as first-line therapy [1-3]. Meanwhile, the
application of self-reported NIH-CPSI implemented in
1999 by the Chronic Prostatitis Collaborative Research
Network (CPCRN) is useful in determining the primary
subjective patient symptoms [13-15]. This questionnaire
has demonstrated a capacity in capturing the qualitative
symptoms of men with CP/CPPS [15].
NIH-CPSI
The data in our study demonstrate the safety of acupunc-
ture and a significant treatment effect on the overall and
individual pain, urinary and QOL symptoms as measured
by administration of the NIH-CPSI following acupunc-
ture treatment (2 times per week over 6 weeks). While
absolute efficacy endpoints can not be established based
on our uncontrolled study, trends regarding specific acu-
puncture application and treatment effects related to
duration of treatment were noted in our study. The signif-
icant reduction in pain sub-scores of the NIH-CPSI fol-
lowing 3 weeks of treatment versus significant reduction
in urinary sub-scores only after 6 weeks of treatment
implies that the treatment effect of acupuncture for pain is
quicker acting than it may be for urinary symptoms. The
effect of acupuncture on pain was further supported by
decreased scores in the bodily pain category of the SF-36,
which were also significant after 3 weeks of treatment.
Quality of life
Emotional health and QOL with regard to social and sex-
ual functioning has been observed in past studies of
chronic prostatitis and co-morbid depression has also
been postulated as a potential factor in the etiology of CP/
CPPS [16,17]. Interestingly, while none of our study
patients were on any current anti-depressant medications,
further analysis of the SF-36 revealed a significant change
in role limitations due to emotional problems versus a
non-significant change in mental health sub-component
(following 3 and 6 weeks of treatment). Although a full
mental health profile was not assessed in our study, these
results are consistent with the hypothesis that chronic
prostatitis may cause significant social and sexual distress
but may not be related to co-morbid depression [18,19].
Previous studies
Further analysis of our study versus two previous pilot
studies testing acupuncture for CP/CPPS also needs to be
addressed [6,7]. It is curious to note that all three studies
(ours included) used three different acupuncture point
prescriptions and protocols (Table 3) and these data dem-
onstrate the complexity of acupuncture clinical trial
design including research methodology challenges, such
Table 2: Mean (SD) summary statistics of SF-36 QOL in 10 patients.
SF-36 Subsets Baseline 0 wk 3 wk 6 wk 12 3 wk vs. 0 6 wk vs. 0 12 wk vs. 0
Physical function 83(15.5) 96(9.4) 97.5(4.2) 98.5(3.3) 0.070 0.016* 0.023*
Role limitation due to physical health 10(10.7) 18.1(10.4) 22.5(7.3) 21.3(7.9) 0.133 0.016* 0.063
Role limitation due to emotional problems 10.8(11.1) 19.2(7.9) 20.8(8.1) 22.5(4.0) 0.148 0.047* 0.027*
Vitality 38.1(11.2) 48.1(13.2) 55.6(16.0) 50.6(17.8) 0.035* 0.037* 0.111
Mental health 63.5(17.0) 64.0(20.1) 72.0(10.9) 76.0(6.6) 0.844 0.211 0.066
Social functioning 43.8(8.8) 52.5(9.9) 57.5(8.7) 60.0(7.9) 0.063 0.008* 0.008*
Bodily pain 45.1(16.1) 76.0(20.1) 87.3(8.8) 88.8(16.5) 0.006* 0.002* 0.004*
General health 47.0(16.0) 58.0(22.5) 60.0(16.0) 61.5(12.3) 0.234 0.061 0.086
SF-36: Short-form 36
*significant: exact Wilcoxon Signed Test P-values
Table 1: Mean (SD) summary statistics of the NIH-CPSI score in 10 patients.
NIH-CPSI Baseline 0 wk 3 P values
 3 wk vs. 0
wk 6 P values
 6 wk vs. 0
wk 12 P values 
12 wk vs. 0
Total score 25.1 (6.6) 17.6 (5.7) 0.006* 8.8 (6.2) 0.006* 6.6 (4.3) 0.006*
Pain scores 9.9 (3.1) 5.3 (4.2) 0.004* 3.1 (2.0) 0.002* 2.1 (2.0) 0.002*
Urinary score 5.7 (3.3) 5.6 (2.5) 0.984 1.7 (2.5) 0.004* 1.6 (1.2) 0.008*
QOL score 9.5 (2.0) 6.7 (2.7) 0.004* 4.1 *2.6) 0.002* 2.9 (2.0) 0.002*
Symptom score = Pain + Urinary 15.6 (5.2) 10.9 (4.1) 0.002* 4.8 (4.0) 0.002* 3.7 (2.9) 0.002*
CPSI: National institutes of health – chronic prostatitis symptom index
* significant: exact Wilcoxon Signed Test P-valuesChinese Medicine 2007, 2:1 http://www.cmjournal.org/content/2/1/1
Page 5 of 7
(page number not for citation purposes)
as the selection of appropriate point prescription, nee-
dling techniques and standardized protocols.
Both of the previous studies reported significant effects of
acupuncture utilizing the NIH-CPSI, whereas the selec-
tions of acupuncture points were different between them
without authors' further explaining of point selection
rationales [6,7]. By contrast, our study had a clear aim to
assess a standardized full body and auricular acupuncture
point prescription based on traditional Chinese medicine
organ (zang-fu) and meridian theory. Our points were
selected in compliance with the traditional principles of
moving qi, easing blood stagnation, relieving pain, and
opening up the meridians (Table 4). In addition, all three
studies used the same endpoint, namely scores on the
NIH-CPSI, and all three studies obtained significance after
six weeks of treatment [6,7].
While these data suggest that acupuncture is beneficial for
symptoms related to CP/CPPS, a number of research
methodological issues, to be addressed in future studies,
were present in the current study. These include selection
of appropriate and homogenous treatment groups with
regard to CP/CPPS such as duration of condition (e.g. >6
months to upwards of 20 years), previous and current bio-
medical treatment(s) and refractory status. Issues concern-
ing acupuncture include high expectation of acupuncture
for refractory patients, utilization of an appropriate, inert
sham-control, acupuncture point selection and applica-
tion of points within or independent of a traditional med-
icine framework.
Potential physiologic mechanisms of action
Research on the hypothesized mechanism of action of
acupuncture for CP/CPPS reveals challenges in both CP/
Table 4: Traditional functions of acupuncture points*.
Name Functions/Point Category
San Jiao 5 (Triple Burner 5) – Wai guan Frees the channels and quickens the connecting vessels, clears heat and resolves toxin, dissipates wind; Luo 
point of the san jiao channel, confluence point of the 8 extraordinary channels
Gall Bladder 41-Zulin qi Courses liver and gallbladder qi stagnation, clears fire and extinguishes wind, transforms obstructing 
phlegm-heat; Shu point, confluence point of the 8 extraordinary channels
Liver 3-Tai chong Extinguishes liver fire, clears liver yang, discharges damp-heat in the lower burner, soothes liver qi, frees 
the channels and quickens the connecting vessels; Shu point, yuan source point
Large Intestine 4-He gu Frees the channels and quickens the connecting vessels, relieves pain and quiets the spirit; Yuan source 
point
Spleen 8-Di ji Harmonizes the spleen and rectifies blood; Xi-cleft point
Spleen 6-San yin jiao Supplements spleen, helps movement and transformation, frees qi stagnation, courses the lower burner; 
Intersection point of spleen channel, one of nine needles for returning yang
Auricular-shen men Promotes relaxation, relieves pain
Auricular-kidney Strengthens the kidneys
Auricular-liver Strengthens gastrointestinal tract, relieves muscle spasms
Auricular-lung Relieves pain
Auricular-spleen Strengthens the gastrointestinal tract, strengthens following a disease
*Adapted from references [10] and [12]
Table 3: Brief characteristics of the three acupuncture studies for CP/CPPS.
Author Sample size CP/CPPS Acupuncture points Duration Significance
Chen et al. 2003 n = 12 IIIA/B Set 1: BL10,23,28,40, KI 10 K1, 
BL67-Bilateral
Set 2: CV3, 4, M-CA-17, SP 6 + 5 hz 
e-stim
Set 3: B:23, BL54, BL35
Three sets of points given 
alternately twice/week over 6 
weeks. 20 minute treatment*
yes CPSI
Honjo et al. 2004 n = 10 IIIB BL 33-Bilateral Single point applied bilaterally over 
4 weeks. 10 minute treatment*
yes CPSI and IPSS
Capodice et al. 2007 n = 10 IIIA/B GB 41, LR 3, LI 4, SJ 5, SP 8, SP 6-
Bilateral Shen men, kidney, liver, 
lung, spleen and one auricle
Twice/week full body and auricular 
acupuncture over 6 weeks. 20–25 
minute treatment (needles in situ)+
yes CPSI
CPSI: National institutes of health – chronic prostatitis symptom index
IPSS: International Prostate Symptom Scores
* no detail on needling procedure
+ detail on needling procedure includes attainment of de qi and needle techniqueChinese Medicine 2007, 2:1 http://www.cmjournal.org/content/2/1/1
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CPPS research and acupuncture research. As aforemen-
tioned, the exact etiology of CP/CPPS is not understood
and no single treatment strategy has been deemed effec-
tive. Moreover, the exact mechanism of action of acupunc-
ture is not clear. Regarding the use of acupuncture for CP/
CPPS, the mechanism of action suggested in one of the
previous studies implies a neuropathic etiology of CP/
CPPS and suggests that one of the treatment effects of acu-
puncture is of a neuro-physiological nature [6].
While we agree that the hypothesis of a neuropathic
model seems plausible, elucidating the exact physiologi-
cal mechanisms of acupuncture for CP/CPPS may ulti-
mately equally demand determination of the exact
pathology of CP/CPPS including the discovery of new sur-
rogate endpoints, biomarkers, and neuromodulatory
mediators involved in inflammation, endocrine function
and their implication in CP/CPPS pathology. We also
hypothesize that acupuncture may have a multi-modal
treatment effect(s) which may include pain relief via
potential anti-inflammatory and neuromodulatory mech-
anisms as well as positive impact on QOL potentially
involving non-specific effects of acupuncture such as
patient-practitioner interaction. These new theories begin
to introduce a biopsychosocial model and mechanism of
CP/CPPS in diagnostic and treatment strategies and may
be useful in future CP/CPPS studies of acupuncture and
other new treatments [20-25].
Limitations
Limitations of this study include small sample size, non-
randomized, non-sham controlled trial design, possible
placebo effect and investigators' bias that may exaggerate
the findings of the study.
In addition, acupuncture was tested in a group of refrac-
tory patients. A recent study testing the use of cipro-
floxacin, tamsulosin or both in refractory CP/CPPS men
showed no clinical effect in any category, and concern
regarding investigation of agents in previous treatment
failures is notable [26]. Recently, the Chronic Prostatitis
Collaborative Research Network [26] and Habmermacher
et al. [27] have proposed a treatment algorithm for newly
diagnosed CP/CPPS patients dependent on subjective
symptoms and a few clinical trials. This algorithm sug-
gests the application of first to third-line medications and
therapies depending on most acute symptoms and histor-
ical treatment outcomes for each related symptom [27].
Therefore, the study of acupuncture as a potential first-
line therapy or as an adjuvant therapy depending on pri-
mary patient who reported subjective symptoms may be
of interest in our future studies. In addition, the complex-
ity and controversy surrounding the design of an appro-
priate placebo for acupuncture research need to be
addressed. Taken together, these challenges facing both
conventional and non-conventional treatment options
for CP/CPPS may generate greater understanding and a
successful treatment for men with CP/CPPS.
Conclusion
The preliminary findings of this pilot study suggest a sig-
nificant and safe treatment effect by acupuncture as meas-
ured by a validated questionnaire, for pain and lower
urinary tract symptoms experienced by men with CP/
CPPS. Data from this and previous studies warrant rand-
omized trials of acupuncture for CP/CPPS in order to
investigate the mechanism of action of acupuncture in
CP/CPPS, via rigorous clinical trial design that may begin
to address the complexity of acupuncture research includ-
ing rationales for acupuncture point selection, treatment
duration, and the ability to determine the effectiveness
and durability of acupuncture in larger, randomized and
multi-center trials.
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